Accel Wealth Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $896K | Sell |
4,830
-343
| -7% | -$63.7K | 0.3% | 81 |
|
|
2025
Q1 | $1.08M | Sell |
5,173
-41
| -0.8% | -$8.59K | 0.39% | 72 |
|
|
2024
Q4 | $927K | Sell |
5,214
-192
| -4% | -$34.1K | 0.35% | 77 |
|
|
2024
Q3 | $1.07M | Sell |
5,406
-303
| -5% | -$59.8K | 0.4% | 64 |
|
|
2024
Q2 | $979K | Buy |
5,709
+804
| +16% | +$138K | 0.39% | 64 |
|
|
2024
Q1 | $893K | Buy |
4,905
+273
| +6% | +$49.7K | 0.38% | 71 |
|
|
2023
Q4 | $718K | Buy |
4,632
+115
| +3% | +$17.8K | 0.36% | 74 |
|
|
2023
Q3 | $673K | Buy |
4,517
+397
| +10% | +$59.2K | 0.38% | 73 |
|
|
2023
Q2 | $555K | Buy |
4,120
+114
| +3% | +$15.4K | 0.31% | 81 |
|
|
2023
Q1 | $638K | Buy |
4,006
+341
| +9% | +$54.3K | 0.26% | 91 |
|
|
2022
Q4 | $592K | Buy |
3,665
+247
| +7% | +$39.9K | 0.28% | 78 |
|
|
2022
Q3 | $485K | Buy |
3,418
+404
| +13% | +$57.3K | 0.26% | 83 |
|
|
2022
Q2 | $463K | Sell |
3,014
-55
| -2% | -$8.45K | 0.27% | 78 |
|
|
2022
Q1 | $499K | Buy |
3,069
+113
| +4% | +$18.4K | 0.26% | 82 |
|
|
2021
Q4 | $400K | Buy |
2,956
+652
| +28% | +$88.2K | 0.2% | 93 |
|
|
2021
Q3 | $248K | Sell |
2,304
-753
| -25% | -$81.1K | 0.16% | 113 |
|
|
2021
Q2 | $344K | Sell |
3,057
-392
| -11% | -$44.1K | 0.23% | 86 |
|
|
2021
Q1 | $373K | Buy |
3,449
+508
| +17% | +$54.9K | 0.3% | 70 |
|
|
2020
Q4 | $315K | Buy |
+2,941
| New | +$315K | 0.29% | 71 |
|